| Year |
Citation |
Score |
| 2024 |
Shi C, De B, Tran Cao HS, Liu S, Florez MA, Kouzy R, Grippin AJ, Katz MHG, Tzeng CD, Ikoma N, Kim MP, Lee S, Willis J, Noticewala SS, Minsky BD, ... ... Taniguchi CM, et al. Escalated-dose radiotherapy for unresected locally advanced pancreatic cancer: Patterns of care and survival in the United States. Cancer Medicine. 13: e7434. PMID 38923407 DOI: 10.1002/cam4.7434 |
0.682 |
|
| 2024 |
Sherry AD, Msaouel P, Kouzy R, Abi Jaoude J, Lin TA, Taniguchi CM, Fuller CD, Minsky B, Ludmir EB. Lost in the plot: missing visual elements in Kaplan-Meier plots of phase III oncology trials. The Oncologist. PMID 38824414 DOI: 10.1093/oncolo/oyae067 |
0.651 |
|
| 2023 |
Taniguchi CM, Frakes JM, Aguilera TA, Palta M, Czito B, Bhutani MS, Colbert LE, Abi Jaoude J, Bernard V, Pant S, Tzeng CD, Kim DW, Malafa M, Costello J, Mathew G, et al. Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial. The Lancet. Oncology. 24: 1387-1398. PMID 38039992 DOI: 10.1016/S1470-2045(23)00478-3 |
0.588 |
|
| 2023 |
Colbert LE, El Alam MB, Wang R, Karpinets T, Lo D, Lynn EJ, Harris TA, Elnaggar JH, Yoshida-Court K, Tomasic K, Bronk JK, Sammouri J, Yanamandra AV, Olvera AV, Carlin LG, ... ... Taniguchi C, et al. Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring. Cancer Cell. PMID 37863066 DOI: 10.1016/j.ccell.2023.09.012 |
0.585 |
|
| 2023 |
Sherry AD, Msaouel P, McCaw ZR, Abi Jaoude J, Hsu EJ, Kouzy R, Patel R, Yang Y, Lin TA, Taniguchi CM, Rödel C, Fokas E, Tang C, Fuller CD, Minsky B, et al. Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy. European Journal of Cancer (Oxford, England : 1990). 194: 113357. PMID 37827064 DOI: 10.1016/j.ejca.2023.113357 |
0.657 |
|
| 2023 |
Sherry AD, Corrigan KL, Kouzy R, Jaoude JA, Yang Y, Patel RR, Totten DJ, Newman NB, Das P, Taniguchi C, Minsky B, Snyder RA, Fuller CD, Ludmir E. Prevalence, trends, and characteristics of trials investigating local therapy in contemporary phase 3 clinical cancer research. Cancer. PMID 37382235 DOI: 10.1002/cncr.34929 |
0.7 |
|
| 2023 |
Florez MA, Jaoude JA, Patel RR, Kouzy R, Lin TA, De B, Beck EJ, Taniguchi CM, Minsky BD, Fuller CD, Lee JJ, Kupferman M, Raghav KP, Overman MJ, Thomas CR, et al. Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials. Jama Network Open. 6: e2313819. PMID 37195664 DOI: 10.1001/jamanetworkopen.2023.13819 |
0.656 |
|
| 2023 |
Elnaggar JH, Huynh VO, Lin D, Hillman RT, Abana CO, El Alam MB, Tomasic KC, Karpinets TV, Kouzy R, Phan JL, Wargo J, Holliday EB, Das P, Mezzari MP, Ajami NJ, ... ... Taniguchi CM, et al. HPV-related anal cancer is associated with changes in the anorectal microbiome during cancer development. Frontiers in Immunology. 14: 1051431. PMID 37063829 DOI: 10.3389/fimmu.2023.1051431 |
0.745 |
|
| 2022 |
Koay EJ, Zaid M, Aliru M, Bagereka P, Van Wieren A, Rodriguez MJ, Jacobson G, Wolff RA, Overman M, Varadhachary G, Pant S, Wang H, Tzeng CW, Ikoma N, Kim M, ... ... Taniguchi CM, et al. Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients with Locally Advanced and Borderline Resectable Pancreatic Cancer: Phase I Trial and Imaging-based Biomarker Validation. International Journal of Radiation Oncology, Biology, Physics. PMID 35863672 DOI: 10.1016/j.ijrobp.2022.06.089 |
0.347 |
|
| 2022 |
Lin D, Alam MBE, Jaoude JA, Kouzy R, Phan JL, Elnaggar JH, Resendiz B, Medrano AYD, Lynn EJ, Nguyen ND, Noticewala SS, Mathew GG, Holliday EB, Minsky BD, Das P, ... ... Taniguchi CM, et al. Microbiome Dynamics During Chemoradiotherapy for Anal Cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 35513187 DOI: 10.1016/j.ijrobp.2022.04.037 |
0.746 |
|
| 2022 |
Moningi S, Lei X, Fang P, Taniguchi CM, Holliday EB, Koay EJ, Koong AC, Ludmir EB, Minsky BD, Das P, Giordano SH, Smith GL. Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer. Clinical and Translational Radiation Oncology. 35: 9-16. PMID 35510142 DOI: 10.1016/j.ctro.2022.04.007 |
0.328 |
|
| 2022 |
Okoro CM, Schüler E, Taniguchi CM. The Therapeutic Potential of FLASH-RT for Pancreatic Cancer. Cancers. 14. PMID 35267474 DOI: 10.3390/cancers14051167 |
0.337 |
|
| 2022 |
Delahoussaye AM, Abi Jaoude J, Green M, Fujimoto TN, Molkentine J, Garcia Garcia CJ, Gay JP, Feng N, Marszalek J, Fowlkes N, Taniguchi CM. Feasibility of administering human pancreatic cancer chemotherapy in a spontaneous pancreatic cancer mouse model. Bmc Cancer. 22: 174. PMID 35172762 DOI: 10.1186/s12885-022-09255-3 |
0.321 |
|
| 2022 |
Bagley AF, Ludmir EB, Maitra A, Minsky BD, Li Smith G, Das P, Koong AC, Holliday EB, Taniguchi CM, Katz MHG, Tamm EP, Wolff RA, Overman MJ, Patel S, Kim MP, et al. NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience. Clinical and Translational Radiation Oncology. 33: 66-69. PMID 35097226 DOI: 10.1016/j.ctro.2021.12.012 |
0.309 |
|
| 2022 |
Colbert LE, Alam MBE, Lynn EJ, Bronk J, Karpinets TV, Wu X, Chapman BV, Sims TT, Lin D, Kouzy R, Sammouri J, Biegert G, Delgado Medrano AY, Olvera A, Sastry KJ, ... ... Taniguchi CM, et al. Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16 Cancers. Cancer Immunology Research. PMID 35045973 DOI: 10.1158/2326-6066.CIR-21-0119 |
0.723 |
|
| 2021 |
Abi Jaoude J, Thunshelle CP, Kouzy R, Nguyen ND, Lin D, Prakash L, Bumanlag IM, Noticewala SS, Niedzielski JS, Beddar S, Ludmir EB, Holliday EB, Das P, Minsky BD, Herman JM, ... ... Taniguchi CM, et al. Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era. Advances in Radiation Oncology. 6: 100763. PMID 34934858 DOI: 10.1016/j.adro.2021.100763 |
0.705 |
|
| 2021 |
Corrigan KL, Kry S, Howell RM, Kouzy R, Jaoude JA, Patel RR, Jhingran A, Taniguchi C, Koong AC, McAleer MF, Nitsch P, Rödel C, Fokas E, Minsky BD, Das P, et al. The Radiotherapy Quality Assurance Gap Among Phase III Cancer Clinical Trials. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 34838891 DOI: 10.1016/j.radonc.2021.11.018 |
0.674 |
|
| 2021 |
Abi Jaoude J, Kouzy R, Rooney M, Thompson P, Patel R, Turner MC, Ghabach M, Fuller CD, Minsky BD, Taniguchi CM, Ludmir EB. Impact factor and citation metrics in phase III cancer trials. Oncotarget. 12: 1780-1786. PMID 34504650 DOI: 10.18632/oncotarget.28044 |
0.675 |
|
| 2021 |
Spiotto MT, Taniguchi CM, Klopp AH, Colbert LE, Lin SH, Wang L, Frederick MJ, Osman AA, Pickering CR, Frank SJ. Biology of the Radio- and Chemo-Responsiveness in HPV Malignancies. Seminars in Radiation Oncology. 31: 274-285. PMID 34455983 DOI: 10.1016/j.semradonc.2021.02.009 |
0.609 |
|
| 2021 |
Garcia Garcia CJ, Abi Jaoude J, Taniguchi CM. Evens Out the Double-Edged Sword of Radiotherapy in Pancreatic Cancer. Cancer Research. 81: 3158-3159. PMID 34224375 DOI: 10.1158/0008-5472.CAN-21-0519 |
0.324 |
|
| 2021 |
Abi Jaoude J, Kouzy R, Ghabach M, Patel R, Pasalic D, Ghossain E, Miller AB, Lin TA, Verma V, Fuller CD, Subbiah V, Minsky BD, Ludmir EB, Taniguchi CM. Food and Drug Administration approvals in phase 3 Cancer clinical trials. Bmc Cancer. 21: 695. PMID 34118915 DOI: 10.1186/s12885-021-08457-5 |
0.648 |
|
| 2021 |
Lin D, Moningi S, Abi Jaoude J, Singh BS, Cazacu IM, Kouzy R, Nogueras Gonzalez GM, Angsuwatcharakon P, Herman JM, Bhutani MS, Taniguchi CM. Development of an Objective Scoring System for Endoscopic Assessment of Radiation-Induced Upper Gastrointestinal Toxicity. Cancers. 13. PMID 33946696 DOI: 10.3390/cancers13092136 |
0.687 |
|
| 2021 |
Moningi S, Abi Jaoude J, Kouzy R, Lin D, Nguyen ND, Garcia Garcia CJ, Phan JL, Avila S, Smani D, Cazacu IM, Singh BS, Smith GL, Holliday EB, Koay EJ, Das P, ... ... Taniguchi CM, et al. Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pancreatic Cancer. Advances in Radiation Oncology. 6: 100621. PMID 33912734 DOI: 10.1016/j.adro.2020.11.006 |
0.713 |
|
| 2021 |
Augustyn A, Reed VI, Ahmad N, Bhutani MS, Bloom ES, Bowers JR, Chronowski GM, Das P, Holliday EB, Delclos ME, Huey RW, Koay EJ, Lee SS, Nelson CL, Taniguchi CM, et al. Implementation of a stereotactic body radiotherapy program for unresectable pancreatic cancer in an integrated community academic radiation oncology satellite network. Clinical and Translational Radiation Oncology. 27: 147-151. PMID 33665384 DOI: 10.1016/j.ctro.2021.02.004 |
0.301 |
|
| 2020 |
Hoffe S, Frakes JM, Aguilera TA, Czito B, Palta M, Brookes M, Schweizer C, Colbert L, Moningi S, Bhutani MS, Pant S, Tzeng CW, Tidwell RS, Thall P, Yuan Y, ... ... Taniguchi CM, et al. Randomized, Double-Blinded, Placebo-controlled Multicenter Adaptive Phase 1-2 Trial of GC 4419, a Dismutase Mimetic, in Combination with High Dose Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (PC). International Journal of Radiation Oncology, Biology, Physics. 108: 1399-1400. PMID 33427657 DOI: 10.1016/j.ijrobp.2020.09.022 |
0.652 |
|
| 2020 |
Abi Jaoude J, Kouzy R, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Pasalic D, Verma V, VanderWalde NA, Smith BD, Smith GL, Fuller CD, Das P, Minsky BD, ... ... Taniguchi CM, et al. Performance Status Restriction in Phase III Cancer Clinical Trials. Journal of the National Comprehensive Cancer Network : Jnccn. 18: 1322-1326. PMID 33022640 DOI: 10.1200/Jco.2020.38.15_Suppl.2059 |
0.699 |
|
| 2020 |
Abi Jaoude J, Kouzy R, El Alam MB, Subbiah V, Taniguchi CM, Ludmir EB, Lin TA. Exclusion of Older Adults in COVID-19 Clinical Trials. Mayo Clinic Proceedings. 95: 2293-2294. PMID 33012364 DOI: 10.1016/j.mayocp.2020.08.018 |
0.615 |
|
| 2020 |
Kouzy R, Abi Jaoude J, Minsky BD, Das P, Koong AC, Subbiah IM, Ludmir EB, Taniguchi CM. Gastrointestinal malignancies and supportive care trials: a snapshot of the last two decades. Bmj Supportive & Palliative Care. PMID 32943466 DOI: 10.1136/Bmjspcare-2020-002538 |
0.715 |
|
| 2020 |
Kouzy R, Abi Jaoude J, Lin D, Nguyen ND, El Alam MB, Ludmir EB, Taniguchi CM. Patient-Reported Outcome Measures in Pancreatic Cancer Receiving Radiotherapy. Cancers. 12. PMID 32887363 DOI: 10.3390/Cancers12092487 |
0.724 |
|
| 2020 |
Kouzy R, Abi Jaoude J, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Verma V, Fuller CD, Minsky BD, Rödel C, Taniguchi CM, Ludmir EB. Professional Medical Writer Assistance in Oncology Clinical Trials. The Oncologist. PMID 32885898 DOI: 10.1634/Theoncologist.2020-0406 |
0.664 |
|
| 2020 |
Kouzy R, Abi Jaoude J, Yue J, Maldonado JA, Taniguchi CM, Ludmir EB, Colbert LE. Applying to Radiation Oncology Amid a Pandemic. Advances in Radiation Oncology. 5: 777-779. PMID 32775792 DOI: 10.1016/J.Adro.2020.06.017 |
0.751 |
|
| 2020 |
Kouzy R, Abi Jaoude J, Garcia Garcia CJ, El Alam MB, Taniguchi CM, Ludmir EB. Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic. Jama Network Open. 3: e2015100. PMID 32658285 DOI: 10.1001/jamanetworkopen.2020.15100 |
0.635 |
|
| 2020 |
Abi Jaoude J, Kouzy R, Minsky BD, Fuller CD, Yuan Y, Do KA, Taniguchi CM, Ludmir EB. Sponsor-Involved Statistical Analyses in Phase III Cancer Clinical Trials. International Journal of Cancer. PMID 32621758 DOI: 10.1002/Ijc.33180 |
0.706 |
|
| 2020 |
Kouzy R, Abi Jaoude J, Lin D, El Alam MB, Minsky BD, Koay EJ, Das P, Holliday EB, Klopp AH, Colbert LE, Taniguchi CM. Patient-Reported GI Outcomes in Patients With Anal Cancer Receiving Modern Chemoradiation. Jco Oncology Practice. OP2000122. PMID 32609585 DOI: 10.1200/Op.20.00122 |
0.767 |
|
| 2020 |
Moningi S, Ajani JA, Badgwell BD, Murphy MB, Ikoma N, Mansfield PF, Ho JC, Suh Y, Crane C, Herman JM, Holliday EB, Koay E, Koong AC, Krishnan S, Minsky B, ... ... Taniguchi C, et al. IMRT Reduces Acute Toxicity in Patients Treated With Preoperative Chemoradiation for Gastric Cancer. Advances in Radiation Oncology. 5: 369-376. PMID 32529130 DOI: 10.1016/J.Ijrobp.2019.06.2046 |
0.437 |
|
| 2020 |
Fuentes NR, Phan J, Huang Y, Lin D, Taniguchi CM. Resolving the HIF paradox in pancreatic cancer. Cancer Letters. PMID 32512024 DOI: 10.1016/J.Canlet.2020.05.033 |
0.376 |
|
| 2020 |
Lin D, Kouzy R, Abi Jaoude J, Noticewala SS, Delgado Medrano AY, Klopp AH, Taniguchi CM, Colbert LE. Microbiome factors in HPV-driven carcinogenesis and cancers. Plos Pathogens. 16: e1008524. PMID 32497113 DOI: 10.1371/Journal.Ppat.1008524 |
0.746 |
|
| 2020 |
Abi Jaoude J, Kouzy R, Nguyen ND, Lin D, Noticewala SS, Ludmir EB, Taniguchi CM. Radiation therapy for patients with locally advanced pancreatic cancer: Evolving techniques and treatment strategies. Current Problems in Cancer. 100607. PMID 32471736 DOI: 10.1016/J.Currproblcancer.2020.100607 |
0.723 |
|
| 2020 |
Colbert LE, Kouzy R, Abi Jaoude J, Ludmir EB, Taniguchi CM. Cancer Research after COVID-19: Where Do We Go from Here? Cancer Cell. 37: 637-638. PMID 32396859 DOI: 10.1016/J.Ccell.2020.04.003 |
0.754 |
|
| 2020 |
Avila S, Chang GJ, Dasari NA, Smani DA, Das P, Herman JM, Koay E, Koong A, Krishnan S, Minsky BD, Smith GL, Taniguchi C, Taggart MW, Kaur H, Holliday EB. Pathologic Response and Postoperative Complications After Short-course Radiation Therapy and Chemotherapy for Patients With Rectal Adenocarcinoma. Clinical Colorectal Cancer. PMID 32173279 DOI: 10.1016/J.Clcc.2020.02.005 |
0.358 |
|
| 2020 |
Gronberg MP, Tailor RC, Smith SA, Kry SF, Followill DS, Stojadinovic S, Niedzielski JS, Lindsay PE, Krishnan S, Aguirre F, Fujimoto TN, Taniguchi CM, Howell RM. A Mail Audit Independent Peer Review System for Dosimetry Verification of a Small Animal Irradiator. Radiation Research. PMID 32068498 DOI: 10.1667/Rr15220.1 |
0.313 |
|
| 2020 |
Koay EJ, Hanania AN, Hall WA, Taniguchi CM, Rebueno N, Myrehaug S, Aitken KL, Dawson LA, Crane CH, Herman JM, Erickson B. Dose-Escalated Radiation Therapy for Pancreatic Cancer: A Simultaneous Integrated Boost Approach. Practical Radiation Oncology. PMID 32061993 DOI: 10.1016/J.Prro.2020.01.012 |
0.428 |
|
| 2020 |
Slagowski JM, Colbert LE, Cazacu IM, Singh BS, Martin R, Koay EJ, Taniguchi CM, Koong AC, Bhutani MS, Herman JM, Beddar S. Evaluation of the Visibility and Artifacts of 11 Common Fiducial Markers for Image-Guided Stereotactic Body Radiation Therapy in the Abdomen. Practical Radiation Oncology. PMID 31988039 DOI: 10.1016/J.Prro.2020.01.007 |
0.604 |
|
| 2020 |
Noticewala SS, Lin D, Kouzy R, Maitra A, Colbert LE, Taniguchi CM. Pancreatic cancer intratumoral microbiome and characteristics within paired patient samples. Journal of Clinical Oncology. 38: 744-744. DOI: 10.1200/Jco.2020.38.4_Suppl.744 |
0.765 |
|
| 2020 |
Kouzy R, Lin D, Noticewala SS, Colbert LE, Taniguchi CM. Enhanced microbial diversity and chemoradiation response in HPV+ anal cancer. Journal of Clinical Oncology. 38: 4-4. DOI: 10.1200/Jco.2020.38.4_Suppl.4 |
0.755 |
|
| 2020 |
Moser EC, Hoffe SE, Frakes J, Aguilera TA, Karim M, Colbert LE, Moningi S, Tzeng CD, Thall PF, Pant S, Bhutani MS, Brookes M, Holmlund J, Herman JM, Taniguchi CM. Adaptive dose optimization trial of stereotactic body radiation therapy (SBRT) with or without GC4419 (avasopasem manganese) in pancreatic cancer. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.Tps4670 |
0.679 |
|
| 2020 |
Jaoude JA, Kouzy R, Mainwaring W, Lin T, Miller AB, Jethanandani A, Espinoza AF, Taniguchi CM, Ludmir EB. Professional medical writing assistance in oncology clinical trials. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E14088 |
0.64 |
|
| 2020 |
Jaoude JA, Kouzy R, Mainwaring W, Lin T, Miller AB, Jethanandani A, Espinoza AF, Ludmir EB, Taniguchi CM. The landscape of gastrointestinal oncologic phase III clinical trials in the last two decades. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E14087 |
0.724 |
|
| 2020 |
Kouzy R, Abi Jaoude J, Lin D, El Alam MB, Minsky BD, Koay EJ, Das P, Holliday EB, Klopp A, Colbert LE, Taniguchi CM. Patient-reported gastrointestinal outcomes in patients with anal cancer. Journal of Clinical Oncology. 38: 4055-4055. DOI: 10.1200/Jco.2020.38.15_Suppl.4055 |
0.763 |
|
| 2020 |
Kouzy R, Jaoude JA, El Alam M, Mainwaring W, Lin T, Miller A, Jethanandani A, Espinoza A, Ludmir E, Taniguchi C. Phase III Radiation Oncology Clinical Trials: A Snapshot of the Last Two Decades International Journal of Radiation Oncology*Biology*Physics. 108: e788-e789. DOI: 10.1016/j.ijrobp.2020.07.259 |
0.678 |
|
| 2020 |
Thunshelle C, Kouzy R, Jaoude JA, Chowdhury T, Zaid M, Mathew R, Prakash L, Katz M, Minsky B, Holliday E, Das P, Smith G, Herman J, Koong A, Taniguchi C, et al. Patient-Reported Outcomes in Prospective Cohort of Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer Undergoing Radiotherapy International Journal of Radiation Oncology*Biology*Physics. 108: e628. DOI: 10.1016/j.ijrobp.2020.07.1897 |
0.691 |
|
| 2020 |
Thunshelle C, Zaid M, Jaoude JA, Chowdhury T, Dai A, Kouzy R, Mathew R, Prakash L, Katz M, Varadhachary G, Tamm E, Minsky B, Holliday E, Das P, Smith G, ... ... Taniguchi C, et al. Neutrophil-Lymphocyte Ratio and Tumor Interface Response as Predictors of Outcomes for Prospective Cohort of Patients with Pancreatic Ductal Adenocarcinoma International Journal of Radiation Oncology*Biology*Physics. 108: e618. DOI: 10.1016/j.ijrobp.2020.07.1873 |
0.639 |
|
| 2020 |
Shobaki D, Bhutani M, Mathew G, Aliru M, Bokhari R, Koay E, Taniguchi C, Herman J. How to Improve Enrollment Onto GI Radiation Oncology Clinical Trials: Lessons Learned From a Brachytherapy Trial for Newly Diagnosed Locally Advanced Pancreatic Cancer International Journal of Radiation Oncology Biology Physics. 108. DOI: 10.1016/J.Ijrobp.2020.02.600 |
0.44 |
|
| 2020 |
Koay E, Bajaj N, Elhammali A, Shiao J, Taniguchi C, Holliday E, Smith G, Das P, Minsky B, Koong A, Herman J, Tzeng C, Vauthey J, Kopetz S. Clinical Associations of Treatment Failure After Radiation Therapy for Colorectal Liver Metastases International Journal of Radiation Oncology Biology Physics. 108. DOI: 10.1016/J.Ijrobp.2020.02.596 |
0.361 |
|
| 2019 |
Coronel E, Singh BS, Cazacu IM, Moningi S, Romero L, Taniguchi C, Herman JM, Bhutani MS. EUS-guided placement of fiducial markers for the treatment of pancreatic cancer. Videogie : An Official Video Journal of the American Society For Gastrointestinal Endoscopy. 4: 403-406. PMID 31517161 DOI: 10.1016/J.Vgie.2019.05.007 |
0.377 |
|
| 2019 |
Moningi S, Ludmir EB, Polamraju P, Williamson T, Melkun MM, Herman JD, Krishnan S, Koay EJ, Koong AC, Minsky BD, Smith GL, Taniguchi C, Das P, Holliday EB. Definitive hyperfractionated, accelerated proton reirradiation for patients with pelvic malignancies. Clinical and Translational Radiation Oncology. 19: 59-65. PMID 31517071 DOI: 10.1016/J.Ctro.2019.08.004 |
0.37 |
|
| 2019 |
Choi GW, Suh Y, Das P, Herman J, Holliday E, Koay E, Koong AC, Krishnan S, Minsky BD, Smith GL, Taniguchi CM, Beddar S. Assessment of setup uncertainty in hypofractionated liver radiation therapy with a breath-hold technique using automatic image registration-based image guidance. Radiation Oncology (London, England). 14: 154. PMID 31470860 DOI: 10.1186/S13014-019-1361-6 |
0.334 |
|
| 2019 |
Bonilla MC, Stemler KM, Jeter-Jones S, Fujimoto TN, Molkentine J, Asencio Torres GM, Zhang X, Broaddus RR, Taniguchi CM, Piwnica-Worms H. Fasting reduces intestinal radiotoxicity enabling dose-escalated radiotherapy for pancreatic cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 31271824 DOI: 10.1016/J.Ijrobp.2019.06.2533 |
0.432 |
|
| 2019 |
Bhutani MS, Cazacu IM, Luzuriaga Chavez AA, Singh BS, Wong FCL, Erwin WD, Tamm EP, Mathew GG, Le DB, Koay EJ, Taniguchi CM, Minsky BD, Pant S, Tzeng CD, Koong AC, et al. Novel EUS-guided brachytherapy treatment of pancreatic cancer with phosphorus-32 microparticles: first United States experience. Videogie : An Official Video Journal of the American Society For Gastrointestinal Endoscopy. 4: 223-225. PMID 31065616 DOI: 10.1016/J.Vgie.2019.02.009 |
0.344 |
|
| 2019 |
Fujimoto TN, Colbert LE, Huang Y, Molkentine JM, Deorukhkar A, Baseler L, Bonilla MC, Yu M, Lin D, Gupta S, Cabeceiras PK, Kingsley CV, Tailor RC, Sawakuchi GO, Koay EJ, ... ... Taniguchi CM, et al. Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer. Cancer Research. 79: 2327-2338. PMID 31043430 DOI: 10.1158/0008-5472.Can-18-1785 |
0.666 |
|
| 2019 |
Molkentine JM, Fujimoto TN, Horvath TD, Grossberg AJ, Garcia CJG, Deorukhkar A, de la Cruz Bonilla M, Lin D, Samuel ELG, Chan WK, Lorenzi PL, Piwnica-Worms H, Dantzer R, Tour JM, Mason KA, ... Taniguchi CM, et al. Enteral Activation of WR-2721 Mediates Radioprotection and Improved Survival from Lethal Fractionated Radiation. Scientific Reports. 9: 1949. PMID 30760738 DOI: 10.1038/S41598-018-37147-9 |
0.437 |
|
| 2019 |
Cazacu IM, Singh BS, Martin R, Slagowski J, Beddar S, Koay E, Taniguchi C, Herman J, Bhutani MS. 923 Endoscopic Ultrasound-Guided Fiducial Placement for Stereotactic Body Radiation Therapy in Patients With Pancreatic Adenocarcinoma American Journal of Gastroenterology. 114: S539-S540. DOI: 10.14309/01.Ajg.0000593228.16482.B4 |
0.371 |
|
| 2019 |
Taniguchi CM, Jhingran A, Stecklein SR, Melancon A, Court L, Ohrt J, Kupferman ME, Msadabwe SC. A pilot course of intensive training in radiation biology and physics for oncologists in sub-Saharan Africa. Journal of Global Oncology. 5: 24-24. DOI: 10.1200/Jgo.2019.5.Suppl.24 |
0.322 |
|
| 2019 |
Moningi S, Ajani JA, Badgwell BD, Mansfield PF, Blum Murphy MA, Ikoma N, Ho J, Suh Y, Holliday EB, Herman JM, Minsky BD, Koay EJ, Koong A, Krishnan S, Smith GL, ... Taniguchi CM, et al. The effect of IMRT on acute toxicity in patients with gastric cancer treated with preoperative chemoradiation. Journal of Clinical Oncology. 37: 153-153. DOI: 10.1200/Jco.2019.37.4_Suppl.153 |
0.388 |
|
| 2019 |
Holmlund J, Brookes M, Colbert LE, Moningi S, Bhutani MS, Katz MHG, Varadhachary GR, Thall PF, Herman JM, Taniguchi CM. Adaptive Dose Escalation Trial of Stereotactic Body Radiation Therapy (SBRT) in combination with GC4419 in pancreatic cancer. Journal of Clinical Oncology. 37. DOI: 10.1200/Jco.2019.37.15_Suppl.Tps4164 |
0.684 |
|
| 2019 |
Abu-Gheida I, Patel A, Zaid M, Elganainy D, Javle MM, Raghav KPS, Vauthey J, Aloia TA, Tzeng CD, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong A, Krishnan S, et al. Outcomes and patterns of failures after hypofractionated radiation therapy for intrahepatic cholangiocarcinoma. Journal of Clinical Oncology. 37: e15609-e15609. DOI: 10.1200/Jco.2019.37.15_Suppl.E15609 |
0.367 |
|
| 2019 |
Garcia CJG, Govindaraju S, Bonilla MdlC, Taniguchi CM. Abstract 3745: Mechanisms of HIF2-mediated small intestine radioprotection Cancer Research. 79: 3745-3745. DOI: 10.1158/1538-7445.Sabcs18-3745 |
0.385 |
|
| 2019 |
Bonilla MdlC, Stemler KM, Jeter-Jones S, Fujimoto TN, Molkentine J, Torres GMA, Taniguchi CM, Piwnica-Worms H. Abstract 3746: Fasting in mice enables abdominal radiation dose escalation in the setting of pancreatic cancer by mitigating small intestinal toxicity Cancer Research. 79: 3746-3746. DOI: 10.1158/1538-7445.Am2019-3746 |
0.42 |
|
| 2019 |
Bernard V, Lucas FAS, Huang J, Powell RT, Guerrero PA, Semaan A, Stephan CC, Davies P, Varadhachary GR, Katz MH, Taniguchi CM, Alvarez HA, Muthuswamy S, Maitra A. Abstract 1402: Single cell transcriptomic profiling ofex vivotumoroid models reveal therapeutic vulnerabilities of pancreatic ductal adenocarcinoma Cancer Research. 79: 1402-1402. DOI: 10.1158/1538-7445.Am2019-1402 |
0.328 |
|
| 2019 |
Aliru M, Bernard V, Ng SP, Moningi S, Lindsay D, Berlind C, Ahern C, Holmes A, Edwards T, Smith B, Taniguchi C, Koay E, Das P, Holliday E, Herman J. Data Analytics Platform for Outcome Comparison of Patients Treated for Primary Pancreatic Cancer Using SBRT vs Conventional RT International Journal of Radiation Oncology*Biology*Physics. 103: E51. DOI: 10.1016/S0360-3016(19)30527-9 |
0.406 |
|
| 2019 |
Moningi S, Aliru M, Lin D, Avila S, Smani D, Koay E, Taniguchi C, Das P, Smith G, Holliday E, Cazacu I, Singh B, Bhutani M, Koong A, Herman J. Does Fiducial Marker Placement Prior to SBRT Increase the Risk of Metastatic Disease in Patients with Unresectable Pancreatic Cancer? International Journal of Radiation Oncology*Biology*Physics. 103: E31. DOI: 10.1016/S0360-3016(19)30472-9 |
0.372 |
|
| 2019 |
Moningi S, Ajani J, Badgwell B, Murphy M, Ikoma N, Ho J, Holliday E, Herman J, Minsky B, Koay E, Koong A, Krishnan S, Smith G, Taniguchi C, Das P. Can IMRT Reduce Lymphopenia in Patients Treated with Preoperative Chemoradiation for Gastric Cancer? International Journal of Radiation Oncology*Biology*Physics. 103: E11. DOI: 10.1016/S0360-3016(19)30425-0 |
0.353 |
|
| 2019 |
Slagowski J, Cazacu I, Martin R, Singh B, Colbert L, Koay E, Taniguchi C, Koong A, Herman J, Bhutani M, Beddar S. Evaluation of the Visibility and Artifacts of Seven Common Fiducials for Image-guided Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 105: E735-E736. DOI: 10.1016/J.Ijrobp.2019.06.833 |
0.605 |
|
| 2019 |
Vichaya E, Estrada D, Ford B, Molkentine J, Vermeer D, Vermeer P, Taniguchi C, Dantzer R. Abstract # 3192 Sex as a biological variable in cancer-related fatigue Brain, Behavior, and Immunity. 76: e40. DOI: 10.1016/J.Bbi.2018.11.302 |
0.356 |
|
| 2019 |
Vichaya E, Grossberg A, Molkentine J, Estrada D, Gross P, Darpolor J, Raj P, Vermeer D, Vermeer P, Taniguchi C, Dantzer R. Abstract # 3157 Elucidating the mechanisms of post-treatment cancer-related fatigue using a preclinical model Brain, Behavior, and Immunity. 76: e32. DOI: 10.1016/J.Bbi.2018.11.274 |
0.33 |
|
| 2018 |
Colbert LE, Rebueno N, Moningi S, Beddar S, Sawakuchi GO, Herman JM, Koong AC, Das P, Holliday EB, Koay EJ, Taniguchi CM. Dose escalation for locally advanced pancreatic cancer: How high can we go? Advances in Radiation Oncology. 3: 693-700. PMID 30370371 DOI: 10.1016/J.Adro.2018.07.008 |
0.66 |
|
| 2018 |
Jensen G, Tao R, Eng C, Skibber JM, Rodriguez-Bigas M, Chang GJ, You YN, Bednarski BK, Minsky BD, Koay E, Taniguchi C, Krishnan S, Das P. Treatment of primary rectal adenocarcinoma after prior pelvic radiation: The role of hyperfractionated accelerated reirradiation. Advances in Radiation Oncology. 3: 595-600. PMID 30370360 DOI: 10.1016/J.Adro.2018.07.003 |
0.404 |
|
| 2018 |
de la Cruz Bonilla M, Stemler KM, Taniguchi CM, Piwnica-Worms H. Stem cell enriched-epithelial spheroid cultures for rapidly assaying small intestinal radioprotectors and radiosensitizers in vitro. Scientific Reports. 8: 15410. PMID 30337664 DOI: 10.1038/S41598-018-33747-7 |
0.331 |
|
| 2018 |
Bernard V, Kim DU, San Lucas FA, Castillo J, Allenson K, Mulu FC, Stephens BM, Huang J, Semaan A, Guerrero PA, Kamyabi N, Zhao J, Hurd MW, Koay EJ, Taniguchi C, et al. Circulating Nucleic Acids Associate with Outcomes of Patients with Pancreatic Cancer. Gastroenterology. PMID 30240661 DOI: 10.1053/J.Gastro.2018.09.022 |
0.374 |
|
| 2018 |
Elganainy D, Holliday EB, Taniguchi CM, Smith GL, Shroff R, Javle M, Raghav K, Kaseb A, Aloia TA, Vauthey JN, Tzeng CD, Herman JM, Koong AC, Krishnan SX, Minsky BD, et al. Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma. Cancer Medicine. PMID 30152073 DOI: 10.1002/Cam4.1734 |
0.363 |
|
| 2018 |
Hunt A, Das P, Minsky BD, Koay EJ, Krishnan S, Herman JM, Taniguchi C, Koong A, Smith GL, Holliday EB. Hyperfractionated abdominal reirradiation for gastrointestinal malignancies. Radiation Oncology (London, England). 13: 143. PMID 30086784 DOI: 10.1186/S13014-018-1084-0 |
0.315 |
|
| 2018 |
Colbert LE, Lin D, Minsky BD, Holliday EB, Klopp A, Das P, Eng C, Morris VK, Taniguchi CM. A prospective biomarker trial of microbiome, immune, and genomic markers as predictors of radiation response in anal squamous cell carcinoma. Journal of Clinical Oncology. 36: TPS869-TPS869. DOI: 10.1200/Jco.2018.36.4_Suppl.Tps869 |
0.625 |
|
| 2018 |
Hester RH, Taniguchi CM, Holliday EB, Koay EJ, Das P, Minsky BD, Rashid A, Mehdizadeh A, Ohinata A, Messick C, You YN, Chang GJ, Bednarski B, Rodriguez-Bigas MA, Skibber JM, et al. CEA as a pharmacodynamic biomarker for metastatic anal cancer. Journal of Clinical Oncology. 36: 684-684. DOI: 10.1200/Jco.2018.36.4_Suppl.684 |
0.328 |
|
| 2018 |
Ng SP, Liu A, Tao R, Holliday EB, Brownlee Z, Kaseb AO, Raghav KPS, Vauthey J, Minsky BD, Herman JM, Das P, Taniguchi CM, Krishnan S, Crane CH, Hong TS, et al. Lymphopenia and outcomes of patients with unresectable hepatocellular carcinoma treated with radiotherapy. Journal of Clinical Oncology. 36: 278-278. DOI: 10.1200/Jco.2018.36.4_Suppl.278 |
0.331 |
|
| 2018 |
Taniguchi CM, Molkentine J, Fujimoto TN, Colbert LE, Deorukhkar A, Herman JM. Effect of stereotactic radiation (SBRT) on survival in a preclinical model of spontaneous pancreatic cancer with induction gemcitabine/nab-paclitaxel. Journal of Clinical Oncology. 36: 273-273. DOI: 10.1200/Jco.2018.36.4_Suppl.273 |
0.66 |
|
| 2018 |
Taniguchi CM, Fujimoto TN, Colbert LE, Moilkentine JM, Deorukhkar A, Baseler LJ, Tailor R, Sawakuchi GO. Abstract 979: EGLN inhibition reduces gastrointestinal radiation toxicity and improves survival in a murine model of locally advanced pancreatic cancer Cancer Research. 78: 979-979. DOI: 10.1158/1538-7445.Am2018-979 |
0.682 |
|
| 2018 |
Bonilla MdlC, Stemler KM, Fujimoto TN, Jeter-Jones S, Molkentine JM, Torres GMA, Taniguchi CM, Piwnica-Worms H. Abstract 4164: Fasting protects mice from lethal radiation by promoting small intestinal stem cell survival Cancer Research. 78: 4164-4164. DOI: 10.1158/1538-7445.Am2018-4164 |
0.404 |
|
| 2018 |
Bernard V, Kim DU, Lucas FAS, Castillo J, Allenson K, Mulu FC, Stephens BM, Huang J, Koay E, Taniguchi CM, Javle M, Wolff RA, Katz MH, Varadhachary GR, Alvarez HA, et al. Abstract 2599: Circulating nucleic acids as biomarkers of prognosis and chemorefractory status in metastatic pancreatic cancer Cancer Research. 78: 2599-2599. DOI: 10.1158/1538-7445.Am2018-2599 |
0.343 |
|
| 2018 |
Molkentine J, Fujimoto T, Horvath T, Grossberg A, Deorukhkar A, Chan W, Lorenzi P, Dantzer R, Tour J, Mason K, Taniguchi C. Gastrointestinal-activated Amifostine Ameliorates Morbid Toxicity from Stereotactic Radiation in a Murine Model International Journal of Radiation Oncology*Biology*Physics. 102: S76. DOI: 10.1016/J.Ijrobp.2018.06.203 |
0.324 |
|
| 2017 |
Holliday EB, Tao R, Brownlee Z, Das P, Krishnan S, Taniguchi C, Minsky BD, Herman JM, Kaseb A, Raghav K, Conrad C, Vauthey JN, Aloia TA, Chun YS, Crane CH, et al. Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombus. Clinical and Translational Radiation Oncology. 4: 39-45. PMID 29594206 DOI: 10.1016/J.Ctro.2017.04.003 |
0.308 |
|
| 2017 |
Holliday EB, Hunt A, You YN, Chang GJ, Skibber JM, Rodriguez-Bigas MA, Bednarski BK, Eng C, Koay EJ, Minsky BD, Taniguchi C, Krishnan S, Herman JM, Das P. Short course radiation as a component of definitive multidisciplinary treatment for select patients with metastatic rectal adenocarcinoma. Journal of Gastrointestinal Oncology. 8: 990-997. PMID 29299359 DOI: 10.21037/Jgo.2017.09.02 |
0.374 |
|
| 2017 |
Colbert LE, Moningi S, Chadha A, Amer A, Lee Y, Wolff RA, Varadhachary G, Fleming J, Katz M, Das P, Krishnan S, Koay EJ, Park P, Crane CH, Taniguchi CM. Dose escalation with an IMRT technique in 15 to 28 fractions is better tolerated than standard doses of 3DCRT for LAPC. Advances in Radiation Oncology. 2: 403-415. PMID 29114609 DOI: 10.1016/J.Adro.2017.02.004 |
0.626 |
|
| 2017 |
Wilke C, Amer A, Elganainy D, Bhosale P, Le O, Lee Y, Cloyd J, Wang H, Herman JM, Taniguchi CM, Rhim A, Fleming JB, Maitra A, Wolff RA, Varadhachary GR, et al. Tumor interface stability on CT imaging is an early marker of response to cytotoxic therapy in pancreatic ductal adenocarcinoma. Journal of Clinical Oncology. 35: 284-284. DOI: 10.1200/Jco.2017.35.4_Suppl.284 |
0.325 |
|
| 2017 |
Kim C, Colbert L, Das P, Minsky B, Krishnan S, Herman J, Holliday E, Taniguchi C, Cloyd J, Vauthey J, Crane C, Koay E. Targeting Multiple Liver Segments, Including the Entire Right Lobe, With Ablative Radiation Therapy as Salvage Therapy for Patients With Colorectal Liver Metastases Not Eligible for Two-Stage Hepatectomy International Journal of Radiation Oncology*Biology*Physics. 99: E160-E161. DOI: 10.1016/J.Ijrobp.2017.06.984 |
0.603 |
|
| 2017 |
Holliday EB, You YN, Chang G, Skibber J, Rodriguez-Bigas M, Bednarski B, Eng C, Koay EJ, Minsky BD, Taniguchi CM, Krishnan S, Herman J, Das P. Short-Course Radiation As a Component of Definitive Multidisciplinary Treatment for Select Patients with Metastatic Rectal Adenocarcinoma International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.970 |
0.354 |
|
| 2017 |
Colbert LE, Fujimoto TN, Molkentine JM, Baseler L, Huang Y, Deorukhkar A, Taniguchi CM. EGLN Inhibition Enables Dose-Escalated Radiation and Improves Survival Through Reduced GI Toxicity and Reduced Micrometastases International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.2095 |
0.615 |
|
| 2017 |
Ng S, Bhosale P, Tamm E, Herman J, Taniguchi C, Das P, Minsky B, Krishnan S, Holliday E, Crane C, Fleming J, Wolff R, Koay E. Utility of Tumor Interface Stability as an Imaging Biomarker of Treatment Outcomes in Patients With Pancreatic Cancer Treated With Concurrent Bevacizumab and Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 99: E175. DOI: 10.1016/J.Ijrobp.2017.06.1020 |
0.429 |
|
| 2017 |
Moningi S, Amer A, Colbert L, Lee Y, Wolff R, Varadhachary G, Das P, Herman JM, Taniguchi C, Fleming JB, Katz MH, Crane C, Le O, Bhosale P, Tamm E, et al. (S022) Can Imaging-Based Biomarkers of Pancreatic Cancer be Used to Select Patients for Dose-Escalated Radiotherapy? International Journal of Radiation Oncology*Biology*Physics. 98: E7. DOI: 10.1016/J.Ijrobp.2017.02.058 |
0.651 |
|
| 2016 |
Entingh AJ, Taniguchi CM, Kahn CR. Bi-directional regulation of brown fat adipogenesis by the insulin receptor. The Journal of Biological Chemistry. 291: 27434. PMID 28039334 DOI: 10.1074/Jbc.A116.303056 |
0.365 |
|
| 2016 |
Suh HN, Jun S, Oh AY, Srivastava M, Lee S, Taniguchi CM, Zhang S, Lee WS, Chen J, Park BJ, Park JI. Identification of KIAA1199 as a Biomarker for Pancreatic Intraepithelial Neoplasia. Scientific Reports. 6: 38273. PMID 27922049 DOI: 10.1038/Srep38273 |
0.392 |
|
| 2016 |
Colbert LE, Dharmarajan KV, Switchenko J, Taniguchi CM, Hall WA, Gillespie TW, Kooby DA, Lipscomb J, Landry JC. Radiation for Pancreatic Adenocarcinoma: An End-of-Life Treatment? Assessing Appropriate Radiation Therapy Utilization in the National Cancer Data Base (NCDB). International Journal of Radiation Oncology, Biology, Physics. 96: S195. PMID 27675761 DOI: 10.1016/J.Ijrobp.2016.06.486 |
0.665 |
|
| 2016 |
Moningi S, Amer A, Colbert LE, Lee Y, Hall WA, Erickson BA, Varadhachary GR, Das P, Taniguchi CM, Fleming JB, Katz M, Crane CH, Koay EJ. A Computed Tomography Imaging Feature of Pancreatic Cancer As a Predictive Biomarker for Escalated Dose Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 96: E171-E172. PMID 27673966 DOI: 10.1016/J.Ijrobp.2016.06.1022 |
0.65 |
|
| 2016 |
Colbert LE, Moningi S, Chadha AS, Wolff RA, Varadhachary GR, Fleming JB, Katz M, Taniguchi CM, Das P, Krishnan S, Koay EJ, Crane CH. Dose Escalation With an Intensity Modulated Radiation Therapy Technique in 15 to 28 Fractions Is Better Tolerated Than Are Standard Doses of 3DCRT for LAPC. International Journal of Radiation Oncology, Biology, Physics. 96: E151-E152. PMID 27673913 DOI: 10.1016/J.Ijrobp.2016.06.971 |
0.614 |
|
| 2016 |
Colbert LE, Fujimoto T, Molkentine J, Deorukhkar A, Taniguchi CM. Prolyl Hydroxylase Inhibitor FG-4592 Radioprotects Against Lethal Fractionated Radiation in a Novel Preclinical Model International Journal of Radiation Oncology Biology Physics. 96. DOI: 10.1016/J.Ijrobp.2016.06.2036 |
0.599 |
|
| 2016 |
Taniguchi C, Kondo T, Sajan M, Luo J, Bronson R, Asano T, Farese R, Cantley L, Kahn C. Divergent Regulation of Hepatic Glucose and Lipid Metabolism by Phosphoinositide 3-Kinase via Akt and PKCλ/ζ Cell Metabolism. 23: 386. DOI: 10.1016/J.Cmet.2016.01.016 |
0.352 |
|
| 2015 |
Taniguchi C, Maitra A. It's a SMAD/SMAD World. Cell. 161: 1245-6. PMID 26046433 DOI: 10.1016/J.Cell.2015.05.030 |
0.375 |
|
| 2014 |
Taniguchi CM, Miao YR, Diep AN, Wu C, Rankin EB, Atwood TF, Xing L, Giaccia AJ. PHD inhibition mitigates and protects against radiation-induced gastrointestinal toxicity via HIF2. Science Translational Medicine. 6: 236ra64. PMID 24828078 DOI: 10.1126/Scitranslmed.3008523 |
0.312 |
|
| 2013 |
Taniguchi CM, Murphy JD, Eclov N, Atwood TF, Kielar KN, Christman-Skieller C, Mok E, Xing L, Koong AC, Chang DT. Dosimetric analysis of organs at risk during expiratory gating in stereotactic body radiation therapy for pancreatic cancer. International Journal of Radiation Oncology, Biology, Physics. 85: 1090-5. PMID 23273994 DOI: 10.1016/J.Ijrobp.2012.07.2366 |
0.427 |
|
| 2012 |
Taniguchi CM, Wu C, Atwood T, Maxim P, Giaccia A. Intestinal HIF-2 to protect against radiation-induced gastrointestinal syndrome. Journal of Clinical Oncology. 30: 10629-10629. DOI: 10.1200/Jco.2012.30.15_Suppl.10629 |
0.351 |
|
| 2012 |
Taniguchi C, Atwood T, Giaccia A. Prolyl Hydroxylase Inhibition Protects Against and Mitigates Radiation-induced Gastrointestinal Toxicity Through Improved Integrity and Function of the GI Epithelium International Journal of Radiation Oncology*Biology*Physics. 84: S106-S107. DOI: 10.1016/J.Ijrobp.2012.07.178 |
0.303 |
|
| 2010 |
Taniguchi CM, Winnay J, Kondo T, Bronson RT, Guimaraes AR, Alemán JO, Luo J, Stephanopoulos G, Weissleder R, Cantley LC, Kahn CR. The phosphoinositide 3-kinase regulatory subunit p85alpha can exert tumor suppressor properties through negative regulation of growth factor signaling. Cancer Research. 70: 5305-15. PMID 20530665 DOI: 10.1158/0008-5472.Can-09-3399 |
0.418 |
|
| 2010 |
Taniguchi C, Kielar K, Murphy J, Atwood T, Christman-Skieller C, Dieterich S, Xing L, Koong A, Chang D. Significant Duodenal Dose Variation within the Respiratory Cycle during Stereotactic Body Radiotherapy for Pancreatic Cancer International Journal of Radiation Oncology*Biology*Physics. 78: S329. DOI: 10.1016/J.Ijrobp.2010.07.780 |
0.398 |
|
| 2010 |
Kielar K, Atwood T, Taniguchi C, Christman-Skieller C, Xing L, Koong A, Chang D. Comparison of RapidArc vs. Conventional Intensity Modulated Radiation Therapy for Stereotactic Body Radiation Therapy for Pancreatic Cancer International Journal of Radiation Oncology*Biology*Physics. 78: S785. DOI: 10.1016/J.Ijrobp.2010.07.1818 |
0.408 |
|
| 2009 |
Sajan MP, Standaert ML, Rivas J, Miura A, Kanoh Y, Soto J, Taniguchi CM, Kahn CR, Farese RV. Role of atypical protein kinase C in activation of sterol regulatory element binding protein-1c and nuclear factor kappa B (NFκB) in liver of rodents used as a model of diabetes, and relationships to hyperlipidaemia and insulin resistance Diabetologia. 52: 1197-1207. PMID 19357831 DOI: 10.1007/S00125-009-1336-5 |
0.37 |
|
| 2009 |
Tseng YH, Kokkotou E, Schulz TJ, Huang TL, Winnay JN, Taniguchi CM, Tran TT, Suzuki R, Espinoza DO, Yamamoto Y, Ahrens MJ, Dudley AT, Norris AW, Kulkarni RN, Kahn CR. Erratum: New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure (Nature (2008) 454 (1000-1004)) Nature. 459. DOI: 10.1038/Nature08038 |
0.347 |
|
| 2008 |
Tseng YH, Kokkotou E, Schulz TJ, Huang TL, Winnay JN, Taniguchi CM, Tran TT, Suzuki R, Espinoza DO, Yamamoto Y, Ahrens MJ, Dudley AT, Norris AW, Kulkarni RN, Kahn CR. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature. 454: 1000-4. PMID 18719589 DOI: 10.1038/Nature07221 |
0.369 |
|
| 2007 |
Taniguchi CM, Aleman JO, Ueki K, Luo J, Asano T, Kaneto H, Stephanopoulos G, Cantley LC, Kahn CR. The p85alpha regulatory subunit of phosphoinositide 3-kinase potentiates c-Jun N-terminal kinase-mediated insulin resistance. Molecular and Cellular Biology. 27: 2830-40. PMID 17283057 DOI: 10.1128/Mcb.00079-07 |
0.372 |
|
| 2006 |
Taniguchi CM, Tran TT, Kondo T, Luo J, Ueki K, Cantley LC, Kahn CR. Phosphoinositide 3-kinase regulatory subunit p85alpha suppresses insulin action via positive regulation of PTEN. Proceedings of the National Academy of Sciences of the United States of America. 103: 12093-7. PMID 16880400 DOI: 10.1073/Pnas.0604628103 |
0.376 |
|
| 2006 |
Taniguchi CM, Kondo T, Sajan M, Luo J, Bronson R, Asano T, Farese R, Cantley LC, Kahn CR. Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide 3-kinase via Akt and PKClambda/zeta. Cell Metabolism. 3: 343-53. PMID 16679292 DOI: 10.1016/J.Cmet.2006.04.005 |
0.376 |
|
| 2006 |
Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nature Reviews. Molecular Cell Biology. 7: 85-96. PMID 16493415 DOI: 10.1038/Nrm1837 |
0.366 |
|
| 2005 |
Tseng YH, Butte AJ, Kokkotou E, Yechoor VK, Taniguchi CM, Kriauciunas KM, Cypess AM, Niinobe M, Yoshikawa K, Patti ME, Kahn CR. Prediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and necdin. Nature Cell Biology. 7: 601-11. PMID 15895078 DOI: 10.1038/Ncb1259 |
0.373 |
|
| 2005 |
Taniguchi CM, Ueki K, Kahn CR. Erratum: Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism (Journal of Clinical Investigation (2005) 115 (718-727) DOI: 10.1172/JCI200523187) Journal of Clinical Investigation. 115. DOI: 10.1172/Jci200523187C1 |
0.388 |
|
| 2003 |
Entingh AJ, Taniguchi CM, Kahn CR. Bi-directional regulation of brown fat adipogenesis by the insulin receptor. The Journal of Biological Chemistry. 278: 33377-83. PMID 12807888 DOI: 10.1074/Jbc.M303056200 |
0.373 |
|
| Show low-probability matches. |
